Schedule 13G ownership disclosure
OXFORD IMMUNOTEC GLOBAL PL
Security class unavailable · CUSIP: G6855A103
Event date: 2015-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.5600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001072613-16-000556
- Form type
- SC 13G
- Filer
- Clarus Lifesciences I, L.P.
- CIK
- CIK 1431445
- Filed
- Feb 09, 2016
- Reporting period
- Dec 31, 2015
- Description
- Schedule 13G beneficial ownership